This website uses cookies primarily for visitor analytics. Certain pages will ask you to fill in contact details to receive additional information. On these pages you have the option of having the site log your details for future visits. Indicating you want the site to remember your details will place a cookie on your device. To view our full cookie policy, please click here. You can also view it at any time by going to our Contact Us page.

Non-invasive wearable ultrasound patch could combat cancer

09 May 2023

A stretchable patch has been developed by a team of engineers that can provide crucial medical information on the progression of diseases and injuries.

Image: UC San Diego Jacobs School of Engineering
Image: UC San Diego Jacobs School of Engineering

Engineers at the University of California San Diego have created a stretchable ultrasonic array capable of serial, non-invasive, three-dimensional imaging of tissues as deep as 4cm below the surface of human skin, at a spatial resolution of 0.5mm. 

This new method provides a non-invasive, longer-term alternative to current methods, with improved penetration depth.
“We invented a wearable device that can frequently evaluate the stiffness of human tissue,” said Hongjie Hu, a postdoctoral researcher in the Xu group and study co-author. 

“In particular, we integrated an array of ultrasound elements into a soft elastomer matrix and used wavy serpentine stretchable electrodes to connect these elements, enabling the device to conform to human skin for serial assessment of tissue stiffness.” 

The elastography monitoring system can provide a serial, non-invasive and three-dimensional mapping of mechanical properties for deep tissues. This has several key applications: 

• In medical research, serial data on pathological tissues can provide crucial information on the progression of diseases such as cancer, which normally causes cells to stiffen

• Monitoring muscles, tendons and ligaments can help diagnose and treat sports injuries

• Current treatments for liver and cardiovascular illnesses, along with some chemotherapy agents, may affect tissue stiffness. Continuous elastography could help assess the efficacy and delivery of these medications. This might aid in creating novel treatments

In addition to monitoring cancerous tissues, this technology can also be applied in other scenarios:

• Monitoring of fibrosis and cirrhosis of the liver. By using this technology to evaluate the severity of liver fibrosis, medical professionals can accurately track the progression of the disease and determine the most appropriate course of treatment

• Assessing musculoskeletal disorders such as tendonitis, tennis elbow and carpal tunnel syndrome. By monitoring changes in tissue stiffness, this technology can provide valuable insight into the progression of these conditions, allowing doctors to develop individualised treatment plans for their patients

• Diagnosis and monitoring for myocardial ischemia. By monitoring arterial wall elasticity, doctors can identify early signs of the condition and make timely interventions to prevent further damage

Wearable ultrasound patches accomplish the detection function of traditional ultrasound and also break through the limitations of traditional ultrasound technology, such as one-time testing, testing only within hospitals and the need for staff operation. 

“This allows patients to continuously monitor their health status anytime, anywhere,” said Hu.

This could help reduce misdiagnoses and fatalities, as well as significantly cutting costs by providing a non-invasive and low-cost alternative to traditional diagnostic procedures.

“This new wave of wearable ultrasound technology is driving a transformation in the healthcare monitoring field, improving patient outcomes, reducing healthcare costs and promoting the widespread adoption of point-of-care diagnosis,” said Yuxiang Ma, a visiting student in the Xu group and study coauthor. 

“As this technology continues to develop, it is likely that we will see even more significant advances in the field of medical imaging and healthcare monitoring.”

The array conforms to human skin and acoustically couples with it, allowing for accurate elastographic imaging validated with magnetic resonance elastography. 

In testing, the device was used to map three-dimensional distributions of Young's modulus of tissues ex vivo, to detect microstructural damage in the muscles of volunteers prior to the onset of soreness and monitor the dynamic recovery process of muscle injuries during physiotherapy.

The device consists of a 16 x 16 array. Each element is composed of a 1-3 composite element and a backing layer made from a silver-epoxy composite designed to absorb excessive vibration, broadening the bandwidth and improving axial resolution.

Print this page | E-mail this page

MinitecBritish Encoder